Top-Rated StocksTop-RatedPositive News SentimentPositive NewsNASDAQ:VRNA Verona Pharma PLC American Depositary Share (VRNA) Stock Price, News & Analysis $93.82 -0.58 (-0.61%) Closing price 06/27/2025 04:00 PM EasternExtended Trading$93.51 -0.31 (-0.33%) As of 06/27/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Verona Pharma PLC American Depositary Share Stock (NASDAQ:VRNA) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get VRNA alerts:Sign Up Key Stats Today's Range$92.88▼$95.2350-Day Range$60.07▼$97.2252-Week Range$14.15▼$99.01Volume951,387 shsAverage Volume1.26 million shsMarket Capitalization$7.99 billionP/E RatioN/ADividend YieldN/APrice Target$101.10Consensus RatingBuy Company OverviewVerona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodilator and an anti-inflammatory agent in a single compound, which is in Phase 3 clinical trials for the treatment of chronic obstructive pulmonary disease, asthma, and cystic fibrosis. It is developing ensifentrine in three formulations, including nebulizer, dry powder inhaler, and pressurized metered-dose inhaler. The company was incorporated in 2005 and is headquartered in London, the United Kingdom.Read More… Verona Pharma PLC American Depositary Share Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks34th Percentile Overall ScoreVRNA MarketRank™: Verona Pharma PLC American Depositary Share scored higher than 34% of companies evaluated by MarketBeat, and ranked 788th out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.5 / 5Analyst RatingBuy Consensus RatingVerona Pharma PLC American Depositary Share has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 11 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageVerona Pharma PLC American Depositary Share has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Verona Pharma PLC American Depositary Share's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Verona Pharma PLC American Depositary Share are expected to grow in the coming year, from ($1.95) to $0.03 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Verona Pharma PLC American Depositary Share is -46.91, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Verona Pharma PLC American Depositary Share is -46.91, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioVerona Pharma PLC American Depositary Share has a P/B Ratio of 36.65. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Verona Pharma PLC American Depositary Share's valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted10.39% of the float of Verona Pharma PLC American Depositary Share has been sold short.Short Interest Ratio / Days to CoverVerona Pharma PLC American Depositary Share has a short interest ratio ("days to cover") of 6.Change versus previous monthShort interest in Verona Pharma PLC American Depositary Share has recently increased by 18.09%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldVerona Pharma PLC American Depositary Share does not currently pay a dividend.Dividend GrowthVerona Pharma PLC American Depositary Share does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted10.39% of the float of Verona Pharma PLC American Depositary Share has been sold short.Short Interest Ratio / Days to CoverVerona Pharma PLC American Depositary Share has a short interest ratio ("days to cover") of 6.Change versus previous monthShort interest in Verona Pharma PLC American Depositary Share has recently increased by 18.09%, indicating that investor sentiment is decreasing significantly. News and Social Media3.1 / 5News Sentiment1.50 News SentimentVerona Pharma PLC American Depositary Share has a news sentiment score of 1.50. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.93 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 7 news articles for Verona Pharma PLC American Depositary Share this week, compared to 7 articles on an average week.Search InterestOnly 7 people have searched for VRNA on MarketBeat in the last 30 days. This is a decrease of -36% compared to the previous 30 days.MarketBeat Follows6 people have added Verona Pharma PLC American Depositary Share to their MarketBeat watchlist in the last 30 days. This is an increase of 500% compared to the previous 30 days. Company Ownership2.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Verona Pharma PLC American Depositary Share insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $20,056,881.00 in company stock.Percentage Held by InsidersOnly 4.80% of the stock of Verona Pharma PLC American Depositary Share is held by insiders.Percentage Held by Institutions85.88% of the stock of Verona Pharma PLC American Depositary Share is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Verona Pharma PLC American Depositary Share's insider trading history. Receive VRNA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Verona Pharma PLC American Depositary Share and its competitors with MarketBeat's FREE daily newsletter. Email Address VRNA Stock News HeadlinesVerona Pharma PLC American Depositary Share (NASDAQ:VRNA) General Counsel Andrew Fisher Sells 80,000 Shares of StockJune 19, 2025 | insidertrades.comVerona Pharma plc (NASDAQ:VRNA) CEO Sells $4,560,000.00 in StockJune 14, 2025 | insidertrades.comTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape. | Paradigm Press (Ad)Verona Pharma plc (NASDAQ:VRNA) CFO Sells $309,076.96 in StockMay 30, 2025 | insidertrades.comVerona Pharma PLC American Depositary Share (NASDAQ:VRNA) Reaches New 52-Week High on Analyst UpgradeJune 25, 2025 | americanbankingnews.comVerona Pharma PLC American Depositary Share (NASDAQ:VRNA) Price Target Raised to $138.00 at Wells Fargo & CompanyJune 21, 2025 | americanbankingnews.comRoth Capital Hikes Verona Pharma’s (VRNA) Price Target to $116 On COPD Market ProspectsJune 20, 2025 | msn.comRoth Capital Reiterates Buy Rating for Verona Pharma PLC American Depositary Share (NASDAQ:VRNA)June 20, 2025 | americanbankingnews.comSee More Headlines VRNA Stock Analysis - Frequently Asked Questions How have VRNA shares performed this year? Verona Pharma PLC American Depositary Share's stock was trading at $46.44 at the beginning of the year. Since then, VRNA shares have increased by 102.0% and is now trading at $93.82. View the best growth stocks for 2025 here. How were Verona Pharma PLC American Depositary Share's earnings last quarter? Verona Pharma PLC American Depositary Share (NASDAQ:VRNA) issued its quarterly earnings data on Tuesday, April, 29th. The company reported $0.27 earnings per share for the quarter, beating the consensus estimate of ($0.22) by $0.49. The business had revenue of $98.65 million for the quarter, compared to the consensus estimate of $41.47 million. Read the conference call transcript. When did Verona Pharma PLC American Depositary Share IPO? Verona Pharma PLC American Depositary Share (VRNA) raised $61 million in an initial public offering (IPO) on Thursday, April 27th 2017. The company issued 4,500,000 shares at a price of $13.49 per share. Jefferies and Stifel acted as the underwriters for the IPO and Wedbush PacGrow and SunTrust Robinson Humphrey were co-managers. Who are Verona Pharma PLC American Depositary Share's major shareholders? Verona Pharma PLC American Depositary Share's top institutional shareholders include Frazier Life Sciences Management L.P. (4.26%), Eventide Asset Management LLC (3.57%), Wellington Management Group LLP (2.63%) and Price T Rowe Associates Inc. MD (2.30%). Insiders that own company stock include David Zaccardelli, Mark W Hahn, Orbimed Advisors Llc, Kathleen A Rickard, Claire Poll, David R Ebsworth, Andrew Fisher, Martin Edwards and Vikas Sinha. View institutional ownership trends. How do I buy shares of Verona Pharma PLC American Depositary Share? Shares of VRNA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Verona Pharma PLC American Depositary Share own? Based on aggregate information from My MarketBeat watchlists, some other companies that Verona Pharma PLC American Depositary Share investors own include Cisco Systems (CSCO), Philip Morris International (PM), NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Home Depot (HD) and CrowdStrike (CRWD). Company Calendar Last Earnings4/29/2025Today6/29/2025Next Earnings (Estimated)8/06/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED - BIOMED/GENE Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:VRNA CIK1657312 Webwww.veronapharma.com Phone011-44-0-2032834200FaxN/AEmployees30Year FoundedN/APrice Target and Rating Average Stock Price Target$101.10 High Stock Price Target$160.00 Low Stock Price Target$57.00 Potential Upside/Downside+7.8%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage11 Analysts Profitability EPS (Most Recent Fiscal Year)($2.00) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$173.42 million Net MarginsN/A Pretax Margin-130.46% Return on Equity-69.65% Return on Assets-28.00% Debt Debt-to-Equity Ratio1.07 Current Ratio8.86 Quick Ratio8.73 Sales & Book Value Annual Sales$42.28 million Price / Sales188.90 Cash FlowN/A Price / Cash FlowN/A Book Value$2.56 per share Price / Book36.65Miscellaneous Outstanding Shares85,130,000Free Float81,046,000Market Cap$7.99 billion OptionableOptionable Beta0.21 The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free Report This page (NASDAQ:VRNA) was last updated on 6/30/2025 by MarketBeat.com Staff From Our PartnersIsrael-Iran WAR Could Destroy Trump's PresidencyThe missiles are already flying. Israel and Iran are now in direct military conflict — and this couldn't ha...American Alternative | SponsoredWhy Is President Trump Fast-Tracking These Companies?Forget about AI… There's a hot new trend on Wall Street… And it's all thanks to President Trump. His ...InvestorPlace | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | Sponsored“Trump’s 24-Hour Profit Windows” revealedTrading legend Larry Benedict has discovered a repeating surge of $240 billion (and more)... Flowing into a...Brownstone Research | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | Sponsored379 passengers walked away from thisElon Musk just wrote a $51 million check to back this material’s next phase… Because it’s not just saving l...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Verona Pharma PLC American Depositary Share Please log in to your account or sign up in order to add this asset to your watchlist. Share Verona Pharma PLC American Depositary Share With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.